Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1422 clinical trials
Featured trial
mjjjjj

This study will assess the safety and tolerability of denosumab in smoldering multiple myeloma subjects as well to see if denosumab can reduce subjects' risk of getting multiple myeloma.

tubal ligation
multiple myeloma
serum calcium
hysterectomy
anemia
  • 0 views
  • 15 May, 2025
  • 1 location
  • Online study
Featured trial
Influence of Occlusal Reduction on Endodontic Postoperative Pain

This study aims to assess the impact of occlusal reduction on post-operative pain after single-visit root canal treatment in patients with necrotic pulps or previously initiated (accessed).

Online studies
  • 0 views
  • 17 May, 2025
  • Online study
Featured trial
Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder (demo)

Double-blind Treatment Phase Participants who demonstrate a treatment response during the Open-label Phase-defined as a ≥50% reduction in GAD-7 score from baseline-will be randomized 1:1 to receive either psilocybin oral solution or placebo at the Double-blind Baseline Visit.

Online studies
  • 0 views
  • 16 May, 2025
  • Online study
Featured trial
SafeBoosC III Two-year Follow-up

The investigators will collect data when the patients are two years of corrected age from routine standardised follow up assessments, parental questionnaires as well as informal assessments. The study will commence in September 2021, and will expect to include all 72 sites across 18 countries, which take part of the …

Online studies
  • 0 views
  • 25 Apr, 2025
  • 1 location
  • Online study
Featured trial
PET MRI as a Staging Tool for Head and Neck Cancer

To explore the use of PET/MRI in the staging and pretreatment evaluation of patients with head and neck cancer and to compare this modality to standard PET/CT imaging.

Online studies
  • 0 views
  • 29 Nov, 2021
  • 1 location
  • Online study
Featured trial
Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)  

The Swiss-Ped-IBrainD is a national patient registry that collects information on diagnosis, symptoms, treatment, and follow-up of pediatric patients with an inflammatory brain disease in Switzerland. It was first implemented in 2020 in the pediatric clinic of the university hospital in Bern. Further centers all over Switzerland were opened for …

Online studies
neuromyelitis optica
multiple sclerosis
optic neuritis
myelitis
  • 0 views
  • 14 Mar, 2022
  • 1 location
  • Online study
Featured trial
Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS) (phaethuSA)

Primary Objective: To evaluate the therapeutic efficacy of one dose level of SAR441344 versus placebo over 12 weeks in adult patients with primary Sjögren's syndrome (pSjS), assessed by the change of the European League Against Rheumatism (EULAR) Sjögren's Syndrome Disease Activity Index (ESSDAI) Secondary Objectives: To evaluate the therapeutic efficacy …

  • 0 views
  • 17 Nov, 2021
  • 28 locations
Featured trial
Prospective Comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the Initial Work-up of Multiple Myeloma (MYELOCHOL)

Our secondary objectives will be to compare the performance of both PET modalities as regard to MRI as well as the detection rate of extra-medullary lesions. Patients with MM will proceed to FCH-PET, FDG-PET and then Whole-Body MRI within 3 weeks.

  • 0 views
  • 03 Dec, 2023
  • 1 location
Featured trial
Consequences of a Maternal-fetal Chikungunya Virus Infection

They were studied around the age of 2 in 33 children in the CHIMERE cohort, as well as at the age of 5 in a small fraction of these children followed at the C.A.M.S.P (Center for Early Medico-Social Action). The results suggested an overall delay in psychomotor acquisitions secondary to …

Accepts healthy volunteers
  • 0 views
  • 14 Mar, 2022
  • 2 locations
Featured trial
Medical Food for the Dietary Management of Metastatic Pancreatic Cancer

Subjects will be receiving two FDA approved first line drug therapies, gemcitabine and nab-paclitaxel (gem+nabP), that are routinely prescribed in combination for metastatic pancreatic cancer as part of their routine care.

  • 0 views
  • 15 Oct, 2021